Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 1;7(9):e1462431.
doi: 10.1080/2162402X.2018.1462431. eCollection 2018.

TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves

Affiliations

TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves

David P Enot et al. Oncoimmunology. .

Abstract

The analysis of tumor growth curves is standard practice in experimental oncology including tumor immunology. In experimental oncology, cancer cells are inoculated into rodents (mostly mice) and their growth is monitored by measuring tumor diameter, surface or volume over time as a function of distinct treatments. Then, different groups of tumors/treatments are compared among each other for their evolution and possible responses to treatment. The R package TumGrowth has been created as a software tool allowing to carry out a series of statistical comparisons across or between groups of tumor growth curves obtained in a standard laboratory, for experimenters with limited knowledge in statistics. TumGrowth is freely available online at https://kroemerlab.shinyapps.io/TumGrowth/ and can be downloaded into any computer. It offers an exhaustive panoply of tools to visualize and analyze complex data sets including longitudinal, cross-sectional and time-to-endpoint measurements.

Keywords: mice; statistical analyses; survival; tumor growth.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overall workflow of the TumGrowth software. After data upload, the user verifies the integrity of the data file, visualizes the experimental outcome while allowing the investigator to choose among several possibilities, then performs several distinct statistical comparisons (longitudinal, cross-sectional, time-to-endpoint) and finally generates publication quality Figs., as well as detailed statistical reports.

Similar articles

Cited by

References

    1. Zitvogel L, Pitt JM, Daillere R, Smyth MJ, Kroemer G. Mouse models in oncoimmunology. Nat Rev Cancer. 2016;16:759–73. doi:10.1038/nrc.2016.91. PMID:27687979. - DOI - PubMed
    1. Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE, Levesque S, Castoldi F, Jacquelot N, Yamazaki T, et al.. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 2016;30:147–60. doi:10.1016/j.ccell.2016.05.016. PMID:27411589. - DOI - PMC - PubMed
    1. Daillere R, Vetizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, et al.. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. 2016;45:931–43. doi:10.1016/j.immuni.2016.09.009. PMID:27717798. - DOI - PubMed
    1. Baracco EE, Pietrocola F, Buque A, Bloy N, Senovilla L, Zitvogel L, Vacchelli E, Kroemer G. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology. 2016;5:e1139275. doi:10.1080/2162402X.2016.1139275. PMID:27471610. - DOI - PMC - PubMed
    1. Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F,Vacchelli E, Souquere S, Sauvat A, et al.. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology. 2016;5:e1149673. doi:10.1080/2162402X.2016.1149673. PMID:27471616. - DOI - PMC - PubMed